About Us

Our mission

Arctoris was founded to enable scientists and biotech entrepreneurs worldwide to make discoveries faster, more efficiently, and enjoy accelerated progress in their research whilst being liberated from manual work. Our goal is to put the most advanced research capabilities at scientists’ fingertips, so that they can find new cures for patients faster.

Our team

The Arctoris team comprises senior cancer researchers, world-leading experts in robotic controls and automation, machine learning engineers, and software engineers. We are supported on our mission by a group of outstanding investors and advisors.

Board of Directors

Martin-Immanuel Bittner MD DPhil

Co-Founder & CEO

Martin completed his medical degree in Germany and his DPhil in Oncology as a Rhodes Scholar at the University of Oxford. He worked in both clinical trials and drug discovery, is actively involved in several European cancer research organisations, and is an elected member of the Young Academy of the German National Academy of Sciences.

Kilian R. Dinkelaker MSc

Co-Founder & CFO

Kilian is a former management consultant and econometrics researcher. He is an expert in tech-driven business creation and finance with extensive industry experience in the European and Asian markets. He graduated from WHU - Otto Beisheim School of Management.

Thomas A. Fleming MChem

Co-Founder & COO

Tom is a cancer researcher and Fellow of the Royal Commission of 1851 at the University of Oxford. A chemist by background, he worked both at leading CROs and pharmaceutical corporations. Tom has unique insights in drug discovery, including all steps from target identification and high-throughput screens to lead optimisation.

John Mattick

Investor director

Professor Mattick is a molecular biologist and life sciences executive. He was the Foundation Director of the Australian Genome Research Facility, Executive Director of the Garvan Institute of Medical Research and CEO of Genomics England. Professor Mattick is an Officer of the Order of Australia and represents RT Partners on the board of Arctoris.

Patrick Pichette

Board advisor

Patrick is a general partner at leading Canadian venture capital firm Inovia Capital, heading their London office, and chairman of Oxford Sciences Innovation, a £600m investment fund affiliated with the University of Oxford. Previously, he was Senior Vice President and CFO of Google, CFO of Bell Canada, and partner at McKinsey.


And a group of exceptional angels and ex-entrepreneurs